Spirometry has made possible the objective assessment of drugs used in the treatment of asthma. Many studies have been carried out to measure the bronchodilator effect of sympathomimetic amines in adults, but few studies on children have been reported. Lukas (1951) studied 6 asthmatic children between the ages of 11 and 16 years during their symptom-free period, and showed that pulmonary function could be improved by the administration of adrenaline hydrochloride subcutaneously or adrenaline by nebulizer. In a study of 30 symptomfree asthmatic children (6-16 years), Kraepelien (1958) measured the lung volume changes before and after bronchodilators, and found that there was a significant lowering of the residual volume (RV), and functional residual capacity (FRC) after these drugs. Pain and Read (1963) measured the vital capacity (VC) and forced expiratory volume in 1 second (FEV1.0), before and after 1 % isoprenaline inhalations in 4 symptomatic asthmatic children (10-13 years). Byrepeatingthesemeasurements daily, they found that the greatest response to therapy was obtained early in an episode of asthma.
Spirometry has made possible the objective assessment of drugs used in the treatment of asthma. Many studies have been carried out to measure the bronchodilator effect of sympathomimetic amines in adults, but few studies on children have been reported. Lukas (1951) studied 6 asthmatic children between the ages of 11 and 16 years during their symptom-free period, and showed that pulmonary function could be improved by the administration of adrenaline hydrochloride subcutaneously or adrenaline by nebulizer. In a study of 30 symptomfree asthmatic children (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) years), Kraepelien (1958) measured the lung volume changes before and after bronchodilators, and found that there was a significant lowering of the residual volume (RV), and functional residual capacity (FRC) after these drugs. Pain and Read (1963) measured the vital capacity (VC) and forced expiratory volume in 1 second (FEV1.0), before and after 1 % isoprenaline inhalations in 4 symptomatic asthmatic children (10-13 years). Byrepeatingthesemeasurements daily, they found that the greatest response to therapy was obtained early in an episode of asthma.
The response to bronchodilators may be underestimated, unless the correct timing for the postbronchodilator tests is chosen. A study was therefore undertaken to measure the response to a bronchodilator in relation to time.
Materials and Methods
Isoprenaline hydrochloride (U.S.P.) was chosen, as it is one of the most active sympathomimetic amines in relaxing the smooth muscle of the bronchial tree when given by inhalation, and acts almost exclusively on the f-receptors of the post-ganglionic adrenergic nerve endings (Goodman and Gilman, 1965) . Two aspects were studied: first, the response to an inhalation was measured at timed intervals to discover when the maximum effect occurred; and second, repeated inhalations showed maximum improvement by 20 minutes. Mushin (1967) , however, found that the peak response in his group of 18 asthmatic patients was not until 30 minutes.
That many of these studies were carried out on heterogeneous groups of patients may account for the varying results: a diagnosis of asthma in children may be made with much greater certainty than in adults. Other factors will also influence the results-the dose of isoprenaline administered, the manner in which the inhalation is given, the type of measurement used to assess response, the interval after administration of the drug at which the post-bronchodilator studies were carried out, and the patient's individual response to the drug.
The pulse rate change does not reflect the bronchodilator effect. Inoue (1967) , measuring the effects of subcutaneous adrenaline on blood glucose, pulmonary function, and heart rate on 6 asthmatic children, found that the effect on the heart rate was much less consistent than its bronchodilator effect. No similar study, comparing heart rate change and bronchodilator effect, has been carried out after isoprenaline inhalations.
There is some discrepancy in previous studies of the relation between the severity of the initial bronchospasm and response to inhalation therapy. Hume and Gandevia (1957) and Hume and Jones (1961) 
